Covid-19 Vaccines : vaccines and mass production
Source: The Pharmaceutical Post n°05 - February 2021
After the moment of truth as to their effectiveness, time has come for large-scale production to pass this test, which is something new, especially for messenger RNA-based vaccines. To meet this health, human, and logistics challenge, CDMOs and packaging manufacturers have been working with laboratories for months in order to ensure the Fill & Finish capabilities and the supply of vials, syringes, caps, insulated boxes, temperature tracers... The challenge is to sustain a progressive increase so that vaccines may reach all over the world and be administered in compliance with pharmaceutical standards.
Read the full article by clicking on the image.
